Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurology process Neurodegenerative disease Parkinson's disease Synuclein

Anti-Alpha-synuclein antibody (ab93432)

Price and availability

328 339 ₸

Availability

Order now and get it on Thursday March 04, 2021

Anti-Alpha-synuclein antibody (ab93432)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to Alpha-synuclein
  • Suitable for: ICC/IF, WB
  • Knockout validated
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Alpha Synuclein Antibody Sampler Panel (ab263465)
Product image
Anti-Alpha-synuclein antibody (ab21976)
Product image
Anti-VCP antibody (ab245346)
Product image
Recombinant Human Alpha-synuclein protein (ab51189)

Overview

  • Product name

    Anti-Alpha-synuclein antibody
    See all Alpha-synuclein primary antibodies
  • Description

    Rabbit polyclonal to Alpha-synuclein
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human Alpha-synuclein aa 100 to the C-terminus conjugated to keyhole limpet haemocyanin.
    (Peptide available as ab105629)

  • Positive control

    • WB: HAP1 (WT) whole cell lysate; Human brain tissue lysate. ICC/IF: SKNSH cells.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Parkinson's disease
    • Synuclein
    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Alzheimer's disease
    • Tangles & Tau

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
    • Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)
  • Recombinant Protein

    • Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab93432 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Guaranteed

Tested applications are guaranteed to work and covered by our Abpromise guarantee.

Predicted

Predicted to work for this combination of applications and species but not guaranteed.

Incompatible

Does not work for this combination of applications and species.

Application Species
ICC/IF
Human
WB
Human
All applications
Mouse
Rat
Chicken
Cow
Pig
Non human primates
Application Abreviews Notes
ICC/IF (1)
Use a concentration of 5 µg/ml.
WB
Use a concentration of 1 µg/ml. Detects a band of approximately 17 kDa (predicted molecular weight: 14 kDa).
Notes
ICC/IF
Use a concentration of 5 µg/ml.
WB
Use a concentration of 1 µg/ml. Detects a band of approximately 17 kDa (predicted molecular weight: 14 kDa).

Target

  • Function

    May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.
  • Tissue specificity

    Expressed principally in brain but is also expressed in low concentrations in all tissues examined except in liver. Concentrated in presynaptic nerve terminals.
  • Involvement in disease

    Genetic alterations of SNCA resulting in aberrant polymerization into fibrils, are associated with several neurodegenerative diseases (synucleinopathies). SNCA fibrillar aggregates represent the major non A-beta component of Alzheimer disease amyloid plaque, and a major component of Lewy body inclusions. They are also found within Lewy body (LB)-like intraneuronal inclusions, glial inclusions and axonal spheroids in neurodegeneration with brain iron accumulation type 1.
    Parkinson disease 1
    Parkinson disease 4
    Dementia Lewy body
  • Sequence similarities

    Belongs to the synuclein family.
  • Domain

    The 'non A-beta component of Alzheimer disease amyloid plaque' domain (NAC domain) is involved in fibrils formation. The middle hydrophobic region forms the core of the filaments. The C-terminus may regulate aggregation and determine the diameter of the filaments.
  • Post-translational
    modifications

    Phosphorylated, predominantly on serine residues. Phosphorylation by CK1 appears to occur on residues distinct from the residue phosphorylated by other kinases. Phosphorylation of Ser-129 is selective and extensive in synucleinopathy lesions. In vitro, phosphorylation at Ser-129 promoted insoluble fibril formation. Phosphorylated on Tyr-125 by a PTK2B-dependent pathway upon osmotic stress.
    Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers.
    Ubiquitinated. The predominant conjugate is the diubiquitinated form.
    Acetylation at Met-1 seems to be important for proper folding and native oligomeric structure.
  • Cellular localization

    Cytoplasm, cytosol. Membrane. Nucleus. Cell junction, synapse. Secreted. Membrane-bound in dopaminergic neurons.
  • Target information above from: UniProt accession P37840 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links

    • Entrez Gene: 6622 Human
    • Entrez Gene: 20617 Mouse
    • Entrez Gene: 641350 Pig
    • Entrez Gene: 29219 Rat
    • Omim: 163890 Human
    • SwissProt: P37840 Human
    • SwissProt: O55042 Mouse
    • SwissProt: P37377 Rat
    • Unigene: 21374 Human
    • Unigene: 17484 Mouse
    • Unigene: 1827 Rat
    see all
  • Alternative names

    • Alpha synuclein antibody
    • Alpha-synuclein antibody
    • Alpha-synuclein, isoform NACP140 antibody
    • alphaSYN antibody
    • MGC105443 antibody
    • MGC110988 antibody
    • MGC127560 antibody
    • MGC64356 antibody
    • NACP antibody
    • Non A beta component of AD amyloid antibody
    • Non A4 component of amyloid antibody
    • Non A4 component of amyloid precursor antibody
    • Non-A beta component of AD amyloid antibody
    • Non-A-beta component of alzheimers disease amyloid , precursor of antibody
    • Non-A4 component of amyloid precursor antibody
    • Non-A4 component of amyloid, precursor of antibody
    • OTTHUMP00000218549 antibody
    • OTTHUMP00000218551 antibody
    • OTTHUMP00000218552 antibody
    • OTTHUMP00000218553 antibody
    • OTTHUMP00000218554 antibody
    • PARK 1 antibody
    • PARK 4 antibody
    • PARK1 antibody
    • PARK4 antibody
    • Parkinson disease (autosomal dominant, Lewy body) 4 antibody
    • Parkinson disease familial 1 antibody
    • SNCA antibody
    • Snca synuclein antibody
    • Snca synuclein, alpha (non A4 component of amyloid precursor) antibody
    • SYN antibody
    • Synuclein alpha antibody
    • Synuclein alpha 140 antibody
    • Synuclein, alpha (non A4 component of amyloid precursor) antibody
    • SYUA_HUMAN antibody
    see all

Images

  • Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Western blot - Anti-Alpha-synuclein antibody (ab93432)

    Lane 1: Wild type HAP1 whole cell lysate (40 µg)
    Lane 2: SNCA knockout HAP1 whole cell lysate (40 µg)
    Lane 3: Human brain tissue lysate (40 µg)
    Lane 4: Mouse brain tissue lysate (40 µg)

    Lanes 1 - 4: Merged signal (red and green). Green - ab93432 observed at 14 kDa. Red - loading control, ab8245, observed at 37 kDa.

    ab93432 was shown to specifically react with SNCA in wild-type HAP1 cells along with additional cross reactive bands. No bands were observed when SNCA knockout samples were used. Wild-type and SNCA knockout samples were subjected to SDS-PAGE. ab93432 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Anti-Alpha-synuclein antibody (ab93432) at 1 µg/ml + Human brain tissue lysate - total protein (ab29466) at 10 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 14 kDa
    Observed band size: 17 kDa why is the actual band size different from the predicted?


    Exposure time: 8 minutes


    Ab934432 detects a band at 17-kDa. While this differs to its predicted molecular weight of 14-kDa, this migration has been observed in the literature (PMID:12042811).
  • Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein antibody (ab93432)
    Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein antibody (ab93432)
    ICC/IF image of ab93432 stained SKNSH cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab93432, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Protocols

  • Western blot protocols
  • Immunocytochemistry & immunofluorescence protocols

Click here to view the general protocols

Datasheets and documents

  • SDS download

  • Datasheet download

    Download

References (0)

Publishing research using ab93432? Please let us know so that we can cite the reference in this datasheet.

ab93432 has not yet been referenced specifically in any publications.

Images

  • Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Western blot - Anti-Alpha-synuclein antibody (ab93432)

    Lane 1: Wild type HAP1 whole cell lysate (40 µg)
    Lane 2: SNCA knockout HAP1 whole cell lysate (40 µg)
    Lane 3: Human brain tissue lysate (40 µg)
    Lane 4: Mouse brain tissue lysate (40 µg)

    Lanes 1 - 4: Merged signal (red and green). Green - ab93432 observed at 14 kDa. Red - loading control, ab8245, observed at 37 kDa.

    ab93432 was shown to specifically react with SNCA in wild-type HAP1 cells along with additional cross reactive bands. No bands were observed when SNCA knockout samples were used. Wild-type and SNCA knockout samples were subjected to SDS-PAGE. ab93432 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Western blot - Anti-Alpha-synuclein antibody (ab93432)
    Anti-Alpha-synuclein antibody (ab93432) at 1 µg/ml + Human brain tissue lysate - total protein (ab29466) at 10 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 14 kDa
    Observed band size: 17 kDa why is the actual band size different from the predicted?


    Exposure time: 8 minutes


    Ab934432 detects a band at 17-kDa. While this differs to its predicted molecular weight of 14-kDa, this migration has been observed in the literature (PMID:12042811).
  • Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein antibody (ab93432)
    Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein antibody (ab93432)
    ICC/IF image of ab93432 stained SKNSH cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab93432, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Alpha-synuclein antibody (ab93432)

  •  
  • Product image

    Anti-Alpha-synuclein antibody [MJFR1] - BSA and Azide free (ab209420)

    Applications: ELISA, Flow Cyt, ICC/IF, IHC-P, IP, WB

  •  
  • Product image

    Anti-Alpha-synuclein antibody [MJFR1] (ab138501)

    Applications: ELISA, Flow Cyt, ICC/IF, IHC-P, IP, WB

  •  
  • Product image

    Anti-Alpha-synuclein (phospho S129) antibody [EP1536Y] - BSA and Azide free (ab209422)

    Applications: Dot, ELISA, IHC-P, WB

  •  
  • Product image

    Anti-Alpha-synuclein (phospho S129) antibody [MJF-R13 (8-8)] - BSA and Azide free (ab209421)

    Applications: WB

  •  
  • Product image

    Anti-Alpha-synuclein antibody [EPR20535] (ab212184)

    Applications: IHC-Fr, IHC-P, IP, WB

  •  
  • Product image

    Anti-Alpha-synuclein (phospho S129) antibody [EP1536Y] (ab51253)

    Applications: Dot, ELISA, IHC-FrFl, IHC-P, WB

  •  
  • Product image

    Anti-Alpha-synuclein (phospho S129) antibody [MJF-R13 (8-8)] (ab168381)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-RPS6 (phospho S235 + S236) antibody (ab65750)

  •  
  • Product image

    PE Anti-SLAMF6 antibody [EPR22170] (ab245902)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.